Delivery Order SPE2DR25D2206-SPE2DR26F9KB7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,994.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This competitively awarded, non-set-aside contract is scheduled for completion by January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 16, 2025. This firm fixed price delivery order, valued at $2,776.22, is scheduled for completion by December 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made competitively. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. Valued at $1,889.21 with a firm fixed price structure, this contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 19, 2025. This delivery order was competitively awarded with no set-aside designation and represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10, with a contract ceiling value of $3,235.68 and ultimate completion date of December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through open competition to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10 on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued under a firm fixed-price delivery order structure, carries a ceiling value of $1,038.01 and is scheduled for completion by December 11, 2025. The award represents a non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,991.36 to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit-dose packages of 10, with an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9KB7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). The contract is valued at $14,926.77 with a completion date of January 8, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger parent company, Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical extending through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor, competes on a full and open basis for federal contracts and demonstrates significant capability in fulfilling government pharmaceutical procurement requirements across multiple therapeutic domains. The Oseltamivir order fulfills critical antiviral medication needs for military treatment facilities and other federal medical institutions. As a key vendor in the Defense Health Agency supply chain, AmerisourceBergen routinely supplies specialty medications, brand-name and generic drugs, vaccines, and other essential medical commodities to support worldwide military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 1/6/26 |